Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Setareh A Williams

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 3, 2025
Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicitiesSetareh A Williams, Rich J Weiss
Diabetes Research and Clinical Practice|January 22, 2011
Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitusSetareh A Williams, Michael F Pollack, Marco Dibonaventura
Journal of Occupational and Environmental Medicine|June 17, 2009
The association between asthma control and health care utilization, work productivity loss and health-related quality of lifeSetareh A Williams, Samuel Wagner, Hema Kannan, et al.
Journal of Drug Assessment|March 6, 2019
Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal womenE Michael Lewiecki, Deane Leader, Richard Weiss, et al.
Diabetes Research and Clinical Practice|December 29, 2009
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of lifeMichael F Pollack, Fanta W Purayidathil, Susan C Bolge, et al.
The Journal of the American Academy of Orthopaedic Surgeons|February 15, 2023
Real-World Management of Patients With Osteoporosis at Very High Risk of FractureBenjamin W Diffenderfer, Yamei Wang, Leny Pearman, et al.
Therapeutic Innovation & Regulatory Science|February 10, 2024
Real-World Evidence to Support the Registration of a New Osteoporosis Medicinal Product in EuropeColleen Davenport, Patricia Gravel, Yamei Wang, et al.
Journal of Occupational and Environmental Medicine|January 29, 2011
The relationship between patient-reported tolerability issues with oral antidiabetic agents and work productivity among patients having type 2 diabetesMarco DiBonaventura, Charles Link, Michael F Pollack, et al.
Rheumatology and Therapy|August 24, 2017
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA RegistryVibeke Strand, Paul Miller, Setareh A Williams, et al.
Journal of Orthopaedic Trauma|February 2, 2023
An Evaluation of Treatment Patterns for Osteoporosis and Outcomes After a Fragility Fracture in a Real-World SettingAndrea J Singer, Setareh A Williams, Leny Pearman, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 3, 2025
Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicitiesSetareh A Williams, Rich J Weiss
Diabetes Research and Clinical Practice|January 22, 2011
Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitusSetareh A Williams, Michael F Pollack, Marco Dibonaventura
Journal of Occupational and Environmental Medicine|June 17, 2009
The association between asthma control and health care utilization, work productivity loss and health-related quality of lifeSetareh A Williams, Samuel Wagner, Hema Kannan, et al.
Journal of Drug Assessment|March 6, 2019
Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal womenE Michael Lewiecki, Deane Leader, Richard Weiss, et al.
Diabetes Research and Clinical Practice|December 29, 2009
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of lifeMichael F Pollack, Fanta W Purayidathil, Susan C Bolge, et al.
The Journal of the American Academy of Orthopaedic Surgeons|February 15, 2023
Real-World Management of Patients With Osteoporosis at Very High Risk of FractureBenjamin W Diffenderfer, Yamei Wang, Leny Pearman, et al.
Therapeutic Innovation & Regulatory Science|February 10, 2024
Real-World Evidence to Support the Registration of a New Osteoporosis Medicinal Product in EuropeColleen Davenport, Patricia Gravel, Yamei Wang, et al.
Journal of Occupational and Environmental Medicine|January 29, 2011
The relationship between patient-reported tolerability issues with oral antidiabetic agents and work productivity among patients having type 2 diabetesMarco DiBonaventura, Charles Link, Michael F Pollack, et al.
Rheumatology and Therapy|August 24, 2017
Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA RegistryVibeke Strand, Paul Miller, Setareh A Williams, et al.
Journal of Orthopaedic Trauma|February 2, 2023
An Evaluation of Treatment Patterns for Osteoporosis and Outcomes After a Fragility Fracture in a Real-World SettingAndrea J Singer, Setareh A Williams, Leny Pearman, et al.
Pageof 5